Loading

Annals of Sports Medicine and Research

Anabolic and Catabolic Steroids in Sports

Mini Review | Open Access | Volume 7 | Issue 1

  • 1. Institute of Sport Sciences and Physiotherapy, University of Tartu, Estonia
+ Show More - Show Less
Corresponding Authors
Teet Seene, Institute of Sport Sciences and Physiotherapy, University of Tartu, Ujula 4, 51008 Tartu, Estonia
Abstract

Intensive and high volume exercise training increase catabolic hormones secretion. Anabolic steroids may block catabolic effect of cortisol, so prevent muscle protein breakdown and speed recovery.To use changes in endogenous hormone ensemble with diferent exercise programs is a part of modern athletes training process. The training purpose of athletes is performance enhancement, Anabolic and anticatabolic effects is possible to use in athletes training and this is the sign of a wise training management. This short review will focus on the anabolic, anticatabolic and catabolic effects of corticosteroids in sports.

Keywords

Anabolic and catabolic steroids , Exercise , Contractile apparatus

Citation

Seene T (2020) Anabolic and Catabolic Steroids in Sports. Ann Sports Med Res 7(1): 1144.

INTRODUCTION

Anabolic steroids in sports is also known as “badboys” drug, because of their use as doping for performance enhancing and winning at any cost purposes. Some athletes take anabolic steroids to increase muscle mass snd strength, others to train harder and recover faster. This is not all the truth about an abolicsteroids. Endogenious anabolic steroids have also important role in fair play or clean competition, as anabolic and anticatabolic effects are usefull in increse of muscle mass, strength. Train harder and recover faster. Intensive and high volume exercise training accompanies with increase of catabolic process is. Anabolic steroids may block catabolic effect of cortisol, so prevent muscle protein breakdown and speed recovery after exercise training. Use of changes in endogenous hormone ensemble is part of modern athletes training program which helps the min performance enhancement and is a sign of a wise training management

Catabolic Action of Corticosteroids

Glucocorticoids, steroid hormones that affect the carbohydrates metabolism, have anti inflammatory effect and many side effects of catabolic action. The catabolic effect of glucocorticoids depends on individual tissues. In contrast to the loss of protein from skeletal muscle, bone, lymphoid tissue, and smooth muscle, there is an increase in the rate of cardiac, hepatic, and urogenital activities [1]. The catabolic action of glucocorticoids in skeletal muscle depends on the type of muscle fibers [2]. Muscle fibers, which have the lowest oxidative capacity (IIB/X) among the striated muscle fibers, are most sensitive to thecatabolic action of glucocorticoids. In these fibers (IIB / X) the activity of non-lysosomal proteases increases significantly after glucocorticoid excess [2]. Excess of glucocorticoids depress testosterone and insulin levels [3,4], although the inhibition of protein synthesis after glucocorticoid administration plays a lesser role in the atrophy of muscle fibers than accelerated protein catabolism [1]. It is well known that the content of lysosomes in type IIB/X muscle fibers is low; the role of lysosomal proteases in the development of corticosteroid myopathy is not significant. The process of atrophy starts from peripheral myosin filaments. Actin filaments are more resistant to the catabolic action of glucocorticoids. Muscle weakness in corticosteroid myopathy is the result of destruction and atrophy of the myofibrils [5].

The higher the degree of atrophy, the lower the muscle elasticity and the higher the tone. Muscle tone is dependent on changes in innervations. It has been shown thatglucocorticoid myopathic fast-twitch (FT) muscles’ neuromuscular synapses are destroyed [6]. A decrease of titin and myosin [7] and of the ratio of nebulin and myosin heavy chain (MyHC) in myopathic muscle [8] shows that these changes in contractile and elastic proteins are the result of elevated catabolism of the above mentioned proteins in skeletal muscle. This is the reason for reduced elasticity and generation of tension in glucocorticoid-caused myopathic muscle.

Catabolic Action and Muscle Function

Moderate endurance type of exercise is effective in retarding muscle atrophy [9] and protecting against wasting [10]. The effect of moderate exercise in inducing a less pronounced catabolic effect of glucocorticoid is caused by the elevation of anticatabolic activity of this type of exercise and related with the endogenous action of androgens in the stimulation of anticatabolic activity in type IIB/X muscle fibers [2]. Skeletal muscles with higher oxidative capacity, particularly slow twitch (ST) fibers, are less sensitive to the catabolicaction of glucocorticoids. This phenomena was explained by the lesser elevation of proteolytic activity in ST Oxydative muscle fibers, but in muscle fibers where oxidative capacity is low (IIB/X), the catabolic activity was more pronounced [11]. As ST oxidative muscle fibers are involved in the maintenance of static body posture, in slow repetitive movements, and being functionally active even when FT fibers are passive, it may be also explain why there is no significant catabolic action of glucocorticoids and atrophy of ST muscle fibers [11]. Atrophy of muscle fibers with low oxidative capacity is the result of inhibition of insulin-like growth factor-1 (IGF-1) [12] and up regulation of two genes, myostatin and glutamatesynthase [13]. Muscle activity increases the synthesis rate of myofibrillar proteins [14] via a mammalian target of rapamycin-activating proteins within the nitrogen-activated protein kinase signalling [15]. The recovery from the last exercise session, particularly from intensive exercise, is faster in the young than in the elderly [16].

Catabolic Action and Contractile Apparatus

Muscle fibers and myofibrils of glucocorticoid-caused myopathic FT glycolytic muscle are thinner. Myosin filaments disappeared completely from one fifth of the area of myofibrils of myopathic muscle [5]. The intensive destruction of myofibrils and degradation of contractile proteins, including MyHC IIb iso form [17], are the main reasons for reduced muscle strength, motor activity, and weakness in glucocorticoid-caused myopathic rats [18,19]. Destruction of myofibrils starts from the periphery of glycolytic muscle fibers. Myosin filaments disappeared from some sarcomeres [11]. The second reason why myofibrils of myopathic muscle fibers are thinner is the slower myofibrillar protein synthesis rate and assembly of filaments. The decrease of the MyHC IIb iso form relative content and the increase of the MyHCIId isoform show that the quantitative changes in myofibrils are significantly related to the qualitative remodelling of thick myofilaments in myopathic glycolytic muscle fibers [18]. Changes in the myofibril ultra structure of myopathic muscle fibers are also related to the functional modification of glycolytic muscle fibers. These modifications were not observed in muscle fibers with higher oxidative capacity in myopathic rodents [18]. Glucocorticoids caused wasting in senescent and young rodents as a result of the loss of FT fibers, their myofibrils, contractile proteins, and conversion of muscle fibers with low oxidative capacity into higher oxidative capacity [18,20]. The MyHC and actin synthesis rate decreased about 20-30% and contractile proteins turned over very slowly after glucocorticoid treatment [1]. In the case of corticosteroid myopathy, sarcopenia, and cachexia, the molecular mechanisms of regulation of muscle, metabolism, and induced wasting disorder-related skeletal muscle atrophy is almost similar [21]. Oxidative capacity of muscle fibers has an important role in anabolic and anticatabolic processes, and in regulation interaction between mitochondrial and myofibrillar compartments [22] including during and after exercise [23].

CONCLUSION

Endogenious an abolicsteroids have an important role in exercise training, as they have anabolic and anticatabolic effects. These effects are important in increse of muscle mass and strength, train harder and recover faster. Catabolic process is accompanies intensive and high volume exercise training. Anabolic steroids may block catabolic effect of cortisol, so prevent muscle protein breakdown and speed recovery. The catabolic effect of glucocorticoids depends on individual tissues. In contrast to the loss of protein from skeletal muscle, bone, lymphoid tissue, and smooth muscle, there is an increase in the rate of cardiac, hepatic, and urogenital activities. The catabolic action of glucocorticoids in skeletal muscle depends on the type of muscle fibers. Muscle fibers, which have the lowest oxidative capacity (IIB/X) among the striated muscle fibers, are most sensitive to the catabolic action of glucocorticoids. Atrophy of muscle fibers with low oxidative capacity is the result of inhibition of insulin-like growth factor-1 (IGF-1) and up regulation of two genes, myostatin and glutamatesynthase. Muscle activity increases the synthesis rate of myofibrillar proteins via a mammalian target of rapamycinactivating proteins within the nitrogen-activated protein kinase signalling. The recovery from the last exercise session, particularly from intensive exercise, is faster in the young than in the elderly. Glucocorticoids caused wasting as a result of the loss of FT fibers, their myofibrils, contractile proteins, and conversion of muscle fibers with low oxidative capacity into higher oxidative capacity. The MyHC and actin synthesis rate decreased by about 20–30% and contractile proteins turned over very slowly after glucocorticoid treatment.

REFERENCES

1. Seene T. Turnover of skeletal muscle contractile proteins in glucocorticoid myopathy. J Steroid Biochem Mol Biol. 1994; 50: 1-4.

2. Seene T, Viru A. The catabolic effect of glucocorticoids on different types of skeletal muscle fibres and its dependence upon muscle activity and interaction with anabolic steroids. J Steroid Biochem. 1982; 16: 349-352.

3. Tomas FM. Effect of corticosterone on myofibrillar protein turnover in diabetic rat as assessed by N-methylhistidine excretion. Biochem J. 1982; 208: 593-601.

4. Smals AG, Kloppenborg PW, Benraad TJ. Plasma testosterone profiles in cushing’s syndrome. J Clin Endocrinol Metab. 1977; 45: 240-245.

5. Kaasik P, Umnova M, Alev K, Selart A, Seene T. Fine architectonics and protein turnover rate in myofibrils of glucocorticoid caused myopathic rats. J Interdiscip Histopathol. 2012; 1: 5-10.

6. Seene T, Umnova M, Kaasik P. The exercise myopathy. In Overload, Performance Incompentence, and Regeneration in Sport; Lehmann M, Foster C, Gastmann U, Keizer H, Steinacker J, Eds. Kluwer Academic/ Plenum Publishers: New York, NY, USA; Boston, MA, USA; Dordrecht, The Netherlands; London, UK; Moscow, Russia, 1999; 119-130.

7. Hayashi K, Tada O, Higuchi K, Ohtsuka A. Effects of cortiosterone on connection content and protein breakdown in rat skeletal muscle. Biosci Biotechnol Biochem. 2000; 64: 2686-2688.

8. Aru M, Alev K, Gapeyeva H, Vain A, Puhke R, Pehme A, et al. Glucocorticoid-induced alterations in titin, nebulin, myosin heavy chain isoform content and viscosoelastic properties of rat skeletal muscle. Adv Biol Chem. 2013; 3: 70-75.

9. Hickson R, Davis J. Partial prevention of glucocorticoid induced muscle atrophy by endurance training. Am J Physiol. 1981; 241: E226-E232.

10. Czerwinski S, Kurowski T, O’Neill T, Hickson R. Initiating regular exercise protects against muscle atrophy from glucocorticoids. J Appl Physiol. 1987; 63: 1504-1510.

11. Seene T, Umnova M, Alev K, Pehme A. Effect of glucocorticoids on contractile apparatus of rat skeletal muscle. J Steroid Biochem. 1988; 29: 313-317.

12. Singleton JR, Baker BL, Thorburn A. Dexamethasone inhibits insulinlike growth factor signaling and potentiates myoblast apoptosis. Endocrinology. 2000; 14: 2945-2950.

13. Carballo-Jane E, Pandit S, Santoro JC, Freund C, Luell S, Harris G, et al. Skeletal muscle: a dual system to measure glucocorticoid-Dependent transactivation and transrepression of gene regulation. J Steroid Biochem Mol Biol. 2004; 88: 191-201.

14. Moore DR, Tang JE, Burd NA, Rerecich T, Tarnopolsky MA, Phillips SM. Differential stimulation of myofibrillar and sarcoplasmic protein synthesis with protein ingestion at rest and after resistance exercise. J Physiol. 2009; 587: 897-904.

15. Moore DR, Atherton PJ, Rennie MJ, Tarnopolsky MA, Phillips SM. Resistance exercise enhances mTOR and MAPK signalling in human muscle over that seen at rest after bolus protein ingestion. Acta Physiol (Oxf). 2011; 201: 365-372.

16. Fell J, Williams D. The effect of aging on skeletal-muscle recovery from exercise: Possible implications for aging athletes. J Aging Phys Act. 2008; 16: 97-115.

17. Fernandez-Rodriques E, Stewart P, Cooper M. The pituitary-adrenal axis and body composition. Pituitary. 2009; 12: 105-115.

18. Seene T, Kaasik P, Pehme A, Alev K, Riso EM. The effect of glucocorticoids on the myosin heavy chain isoforms’ turnover in skeletal muscle. J Steroid Biochem Mol Biol. 2003; 86: 201-206.

19. Kaasik P, Umnova M, Pehme A, Alev K, Aru M, Selart A, et al. Ageing and dexamethasone associated sarcopenia: Peculiarities of regeneration. J Steroid Biochem Mol Biol. 2007; 105: 85-90.

20. Holloszy JO, Chen M, Cartee GD, Young JC. Skeletal muscle atrophy in old rats: Defferential changes in threefiber types. Mech Ageing Dev. 1991; 60: 199-213.

21. Seene T, Kaasik P. Role of myofibrillar protein catabolism in development of glucocorticoidmyopathy: Aging and functional activity aspects. Metabolites. 2016; 6: 15.

22. Seene T, Kaasik P, Seppet E. Crosstalk between mitochondria and myofibrils in adult and aging striated muscle tissue: Effect of increased functional activity. Asian J Res Med Pharm Sci. 2017; 1: 1-11.

23. Seene T, Kaasik P. Physical activity in prevention of glucocorticoid myopathy. In: Aging exploring a complex phenomenon. Edn. Shamim I Ahmad. CRC Press, Taylor & Frances Group. 2018; 543-557.

Seene T (2020) Anabolic and Catabolic Steroids in Sports. Ann Sports Med Res 7(1): 1144

Received : 02 Mar 2020
Accepted : 21 Mar 2020
Published : 24 Mar 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X